journal article·2007-08

Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate

Payal Agrawal, Umesh Gupta, N.K. Jain

Biomaterials· Volume 28· Issue 22
Publisher page

Abstract

Dendrimers consisting of different molecules of metabolic pathways such as amino acids can greatly reduce the toxicity associated with amine-terminated dendrimers e.g. polyamidoamine (PAMAM) and polypropylene imine (PPI) dendrimers. In the present study, poly-L-lysine dendrimers having polyethyleneglycol (PEG-1000) as core, were synthesized upto fourth generation. Dendrimers were synthesized by alternating protection and deprotection steps of L-lysine by di-BOC (di-tertiary butyl pyrocarbonate) till the formation of 4.0 G peptide dendrimer took place. D-galactose was selected as model sugar for peripheral conjugation (coating) of these peptide dendrimer. The complete formation of uncoated and galactose-coated poly-L-lysine dendrimers was characterized by transmission electron microscopy (TEM), IR, NMR and MALDI TOF mass spectroscopic studies. Chloroquine phosphate (CP)-loaded uncoated and coated dendrimers were evaluated for in vitro drug release rate, hemolytic toxicity and stability studies. Ex vivo cellular uptake studies of uncoated and coated drug dendrimer formulations in macrophages revealed almost 5 times reduced phagocytosis due to galactose coating (p<0.0001). In vitro-in vivo release behavior indicated possibilities of galactose-coated drug dendrimers formulation in controlled drug delivery of CP. Galactose coated formulations drastically reduced hemolytic toxicity compared to uncoated poly-L-lysine formulation as well as plain drug. Hematological data suggests that galactose-coated formulations are less immunogenic compared to uncoated formulations. Finally, it can be concluded that galactose-coated polylysine dendrimers can be utilized for controlled delivery of CP more safely compared to its uncoated formulation both in vitro and in vivo.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery · Chemical Synthesis and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (47)

Show source-provided references
1. Design of sustained release nitrendipine microspheres having solid dispersion structure by quasi emulsion solvent diffusion method10.1016/S0168-3659(03)00275-X ↗
2. Polymeric microspheres as drug carriers10.1016/0142-9612(88)90081-6 ↗
3. A polymeric micelle system with a hydrolysable segment for drug delivery10.1163/156856206776986297 ↗
4. Nanoparticles in drug delivery
5. A PEGylated dendritic nanoparticulate carrier of fluorouracil10.1016/S0378-5173(03)00132-7 ↗
6. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting10.1016/j.ijpharm.2005.01.026 ↗
7. PEGylated peptide based dendritic nanoparticulate systems for delivery of artemether10.1016/S1773-2247(05)50008-X ↗
8. Polyester dendrimer systems for drug delivery applications design, synthesis and characterization10.1021/bc010102u ↗
9. Polyamindo amine dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide10.1016/j.jconrel.2004.09.015 ↗
10. A review of in vitro–in vivo investigations on dendrimers: the novel nanoscopic carriers10.1016/j.nano.2006.04.002 ↗
11. A new class of polymers: starburst-dendritic macromolecules10.1295/polymj.17.117 ↗
12. Efficient transfer of genetic material into mammalian cells by using starburst polyamido amine dendrimers10.1073/pnas.93.10.4897 ↗
13. In vitro gene delivery by degraded polyamidoamine dendrimers10.1021/bc9600630 ↗
14. Dendrimers in drug research10.1039/b309043b ↗
15. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications10.1016/S1359-6446(01)01757-3 ↗
16. Catalysis using peripherally functionalized dendrimers
17. Catalysis inside dendrimers10.1039/b107812g ↗
18. Functional dendrimers for non-linear optics10.1002/1521-4095(200108)13:15<1201::AID-ADMA1201>3.0.CO;2-F ↗
19. Antenna effects of aromatic dendrons and their luminescence applications10.1007/b11011 ↗
20. Use of antiscalants for mitigation of silica (SiO2) fouling and deposition: fundamentals and applications in desalination systems10.1016/j.desal.2004.06.135 ↗
21. Dendrimers: novel polymeric nanoarchitectures for solubility enhancement10.1021/bm050802s ↗
22. Dendimers and dendritic polymer in drug delivery10.1016/S1359-6446(04)03276-3 ↗
23. Peptide dendrimers applications and synthesis10.1016/S1389-0352(01)00061-7 ↗
24. Dendrimers of citric acid and poly (ethylene glycol) as the new drug delivery agents10.1016/j.biomaterials.2004.04.014 ↗
25. Synthesis of Polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs10.1021/bc0000583 ↗
26. Design and synthesis of glycodendrimers10.1016/S1389-0352(01)00062-9 ↗
27. Rockendorf N, Lindhorst TK. Dendrimers IV, topics in current chemistry, vol. 217. New York: Springer; 2001. p. 201–38.10.1007/3-540-45003-3_6 ↗
28. Mannose functionalization of a sixth generation of dendrimer10.1021/bm015560k ↗
29. Wedge like glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins lactose maxiclusters and cell surface glycoconjugate10.1002/1439-7633(20011105)2:11<822::AID-CBIC822>3.0.CO;2-W ↗
30. Carbohydrate specific receptors of liver10.1146/annurev.bi.51.070182.002531 ↗
31. Hardmen JG, Limbird LE, Gilman AG. The pharmacological basis of therapeutics, Xth ed. USA: McGraw-Hill Companies; 2001. p. 1069–78.
32. Quantitative monitoring of solid phase peptide synthesis by the ninhydrin reaction10.1016/0003-2697(81)90704-1 ↗
33. A direct method for the formation of peptide and carbohydrate dendrimers10.1016/S0960-894X(99)00480-1 ↗
34. Dynamics of Bengal Rose encapsulated in the Meijer dendrimer box10.1021/ja964230i ↗
35. Martin · 1991
36. Evaluation of an aqueous injection of Ketoprofen
37. Polymeric micelles for solubilization and haemolytic activity of Amphotericin B10.1016/S0168-3659(97)00245-9 ↗
38. Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro10.1016/S0264-410X(02)00521-2 ↗
39. Analysis of poly (d,l-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro10.1023/A:1020452531828 ↗
40. Beta alanine based dendritic beta peptides: dendrimers possessing unusually strong binding ability towards protic solvents and their self assembly into nanoscale aggregates through hydrogen bond interaction10.1002/1521-3765(20010202)7:3<686::AID-CHEM686>3.0.CO;2-Z ↗
41. Encapsulation of guest molecules into a dendritic box10.1126/science.266.5188.1226 ↗
42. Dendrimers: Relationship between structure and preliminary studies on the biodistribution of 125I- labeled polyamidoamine dendrimers in vivo10.1016/S0168-3659(99)00246-1 ↗
43. Dendrimers: biocompatibility and potential for delivery of anticancer agents
44. Gaspar · Ann Trop Med Parasit · 1992 · 86 · 4110.1080/00034983.1992.11812629 ↗
45. Preparation, physicochemical and pharmacokinetic characterization of monomethoxy poly(ethylene glycol), derivatized superoxide dimutase10.1016/0168-3659(89)90025-4 ↗
46. Dendrimers in biomedical applications reflections on the field10.1016/j.addr.2005.09.018 ↗
47. Dendrimer biocompatibility and toxicity10.1016/j.addr.2005.09.019 ↗